John Morales
- Medical Treatment
- January 31, 2023
- 5 views
Liver cancer treatment costly for Medicare patients, UT Southwestern study finds: Newsroom
Liver cancer is forecast to be the No. 3 induce of cancer deaths by 2040, said Dr. Amit Singal and his colleagues. Cancer procedure fees in the United States are…
- Women'S Health
- January 28, 2023
- 6 views
Peloton’s Leanne Hainsby Reveals Breast Cancer Symptom and Diagnosis at 35
Peloton instructor Leanne Hainsby just shared some challenging news with her followers. In an psychological Instagram article, the 35-year-outdated exposed that she’s been battling breast cancer for the earlier 6…
- Women'S Health
- January 22, 2023
- 5 views
Opinion: Women don’t have to die from cervical cancer
Editor’s Observe: Dr. Eloise Chapman-Davis is director of gynecologic oncology at NewYork-Presbyterian/Weill Cornell Clinical Heart and Weill Cornell Drugs. Dr. Denise Howard is chief of obstetrics and gynecology at NewYork-Presbyterian…
- Health Update
- January 19, 2023
- 7 views
Riverdance legend Michael Flatley shares health update with hospital release picture after ‘aggressive cancer’ diagnosis
MICHAEL Flatley has certain enthusiasts that he’s on the mend immediately after therapy for most cancers. The superhoofer posted a picture to say he experienced been introduced from the healthcare…
- Medical Treatment
- January 16, 2023
- 6 views
Cancer centre funding boost to widen UK trials of ‘treatments of the future’ | Cancer
Cancer clients will have greater obtain to medical trials of personalised therapies right after a funding raise for specialised healthcare centres made to make new therapies available as before long…
- Medical Treatment
- December 30, 2022
- 5 views
Hoth Therapeutics Announces FDA Acceptance of IND Application for HT-001 for the Treatment of Cancer Disorders Associated with Epidermal Growth Factor Receptor (EGFR) Inhibitor Therapy
On-monitor to initiate Phase 2 demo in Q1 2023 NEW YORK, Dec. 29, 2022 /PRNewswire/ — Hoth Therapeutics, Inc. (NASDAQ: HOTH), a affected individual-focused biopharmaceutical company, these days announced that the…
